| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NXSTAGE MED INC COM | 356,509 | 7,729,000 | 6.13% | SH | |
| 2 | ATRICURE INC | 513,946 | 7,262,000 | 5.76% | SH | |
| 3 | VITAE PHARMACEUTICALS INC | 660,188 | 7,123,000 | 5.65% | ||
| 4 | DERMIRA INC | 193,642 | 5,664,000 | 4.49% | ||
| 5 | ABBVIE INC | 76,331 | 4,726,000 | 3.75% | ||
| 6 | ALDER BIOPHARMACEUTICALS INC | 165,313 | 4,128,000 | 3.27% | ||
| 7 | RIGEL PHARMACEUTICAL INC | 1,847,087 | 4,119,000 | 3.26% | SH | |
| 8 | NOVAVAX INC COM | 550,000 | 3,999,000 | 3.17% | ||
| 9 | CYNAPSUS THERAPEUTICS INC | 222,359 | 3,718,000 | 2.95% | ||
| 10 | GALAPAGOS NV | 63,568 | 3,526,000 | 2.79% | ||
| 11 | NEUROCRINE BIOSCIE COM USD0.001 | 75,503 | 3,432,000 | 2.72% | SH | |
| 12 | AERIE PHARMACEUTICALS INC | 160,869 | 2,831,000 | 2.24% | SH | |
| 13 | INSULET CORPORATION | 92,164 | 2,787,000 | 2.21% | SH | |
| 14 | TESARO INC | 30,000 | 2,522,000 | 2.00% | ||
| 15 | LOXO ONCOLOGY INC COM | 101,966 | 2,364,000 | 1.87% | ||
| 16 | APPLIED GENETIC TECHNOL CORP | 167,192 | 2,362,000 | 1.87% | ||
| 17 | TANDEM DIABETES CARE INC | 312,756 | 2,358,000 | 1.87% | ||
| 18 | INSULET CORP 2 06/15/2019 | 2,407,000 | 2,294,000 | 1.82% | PRN | |
| 19 | IMMUNOMEDICS INC | 815,000 | 1,891,000 | 1.50% | ||
| 20 | ACHILLION PHARMACEUTICALS INC COM | 236,500 | 1,845,000 | 1.46% | SH | |
| 21 | AEGLEA BIOTHERAPEUTICS INC COM | 350,392 | 1,703,000 | 1.35% | ||
| 22 | PROTALIX BIOTHERAPEUTICS INC | 2,500,000 | 1,644,000 | 1.30% | PRN | |
| 23 | BIOTELEMETRY INC COM | 100,000 | 1,630,000 | 1.29% | SH | |
| 24 | ZOGENIX INC | 197,538 | 1,590,000 | 1.26% | ||
| 25 | BIOSPECIFICS TECHNOLOGIES CORP COM | 39,704 | 1,586,000 | 1.26% | SH | |
| 26 | ISHARES TR | 6,000 | 1,544,000 | 1.22% | ||
| 27 | SPECTRANETICS CORP | 79,812 | 1,493,000 | 1.18% | SH | |
| 28 | MACROGENICS INC | 54,200 | 1,463,000 | 1.16% | ||
| 29 | CYTOKINETICS INC | 150,000 | 1,424,000 | 1.13% | ||
| 30 | DERMA SCIENCES INC COM PAR .01 | 353,718 | 1,394,000 | 1.10% | SH | |
| 31 | RADIUS HEALTH | 37,600 | 1,382,000 | 1.10% | ||
| 32 | Stereotaxis Inc | 1,372,862 | 1,345,000 | 1.07% | SH | |
| 33 | CARA THERAPEUTICS INC | 267,046 | 1,284,000 | 1.02% | ||
| 34 | XENON PHARMACEUTICALS INC | 214,091 | 1,263,000 | 1.00% | ||
| 35 | Foamix Pharmaceuticals Ltd. | 192,567 | 1,223,000 | 0.97% | ||
| 36 | REGULUS THERAPEUTICS INC | 421,500 | 1,218,000 | 0.97% | ||
| 37 | SYNERGY PHARMACEUTICALS DEL COM NEW | 319,563 | 1,214,000 | 0.96% | ||
| 38 | CORBUS PHARMACEUTICALS HLDGS COM | 400,000 | 1,196,000 | 0.95% | ||
| 39 | ACHAOGEN INC COM | 314,341 | 1,191,000 | 0.94% | ||
| 40 | UNIQURE NV | 158,907 | 1,171,000 | 0.93% | SH | |
| 41 | JOHNSON & JOHNSON | 9,400 | 1,140,000 | 0.90% | SH | |
| 42 | LDR HLDG CORP COM | 30,000 | 1,109,000 | 0.88% | ||
| 43 | WINDTREE THERAPEUTICS INC | 533,358 | 1,029,000 | 0.82% | ||
| 44 | NOVADAQ TECHNOLOGIES INC | 101,841 | 1,002,000 | 0.79% | SH | |
| 45 | Exactech Inc | 31,636 | 846,000 | 0.67% | SH | |
| 46 | MINERVA NEUROSCIENCES INC COM | 80,100 | 818,000 | 0.65% | ||
| 47 | ESSA Pharma | 202,496 | 810,000 | 0.64% | ||
| 48 | GERON CORP | 285,000 | 764,000 | 0.61% | ||
| 49 | CONCERT PHARMACEUTICALS INC COM | 66,968 | 752,000 | 0.60% | ||
| 50 | Ascendis Pharma | 53,241 | 707,000 | 0.56% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-16-000031, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
